Skin discoloration with FTC.
D017326:Clinical Trials, Phase III as Topic; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000068679:Emtricitabine; D006801:Humans; D010859:Pigmentation Disorders / Q000139:chemically induced*
D003841:Deoxycytidine; D000068679:Emtricitabine